The impact of receiving polygenic risk scores for alcohol use disorder on psychological distress, risk perception, and intentions to reduce drinking

被引:2
|
作者
Driver, Morgan N. [1 ]
Kuo, Sally I-Chun [2 ]
Dron, Jacqueline S. [3 ]
Austin, Jehannine [4 ,5 ]
Dick, Danielle M. [2 ,6 ]
机构
[1] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA
[2] Rutgers State Univ, Dept Psychiat, Robert Wood Johnson Med Sch, Piscataway, NJ USA
[3] Massachusetts Gen Hosp, Ctr Genom Med, Dept Med, Boston, MA USA
[4] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada
[5] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
[6] Rutgers State Univ, Rutgers Addict Res Ctr, Brain Hlth Inst, Piscataway, NJ USA
关键词
alcohol use disorder; genetic risk; personalized medicine; polygenic risk scores; prevention; GENETIC SUSCEPTIBILITY; METAANALYSIS; ATTITUDES;
D O I
10.1002/ajmg.b.32933
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
For the return of polygenic risk scores to become an acceptable clinical practice in psychiatry, receipt of polygenic risk scores must be associated with minimal harm and changes in behavior that decrease one's risk for developing a psychiatric outcome. Data from a randomized controlled trial was used to assess the impact of different levels of hypothetical polygenic risk scores for alcohol use disorder on psychological distress, risk perception, and intentions to change drinking behaviors. The analytic sample consisted of 325 participants recruited from an urban, public university. Results demonstrated that there were significant increases in psychological distress as the level of genetic risk for alcohol use disorder increased. In addition, the perceived chance of developing alcohol use disorder significantly increased as the level of genetic risk increased. Promisingly, a greater proportion of participants indicated that they would intend to engage in follow-up behaviors, such as seeking additional information, talking to a healthcare provider about risk, and reducing drinking behaviors, as the level of genetic risk increased. Returning polygenic risk scores for alcohol use disorder in a clinical setting has the potential to promote risk-reducing behavior change, especially with increasing levels of genetic risk. The study was registered on (Identifier: NCT05143073).
引用
收藏
页码:93 / 101
页数:9
相关论文
共 39 条
  • [1] Evaluating the impact of a new educational tool on understanding of polygenic risk scores for alcohol use disorder
    Driver, Morgan N. N.
    Kuo, Sally I-Chun
    Petronio, Lia
    Brockman, Deanna
    Dron, Jacqueline S. S.
    Austin, Jehannine
    Dick, Danielle M. M.
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [2] Evaluating risk for alcohol use disorder: Polygenic risk scores and family history
    Lai, Dongbing
    Johnson, Emma C.
    Colbert, Sarah
    Pandey, Gayathri
    Chan, Grace
    Bauer, Lance
    Francis, Meredith W.
    Hesselbrock, Victor
    Kamarajan, Chella
    Kramer, John
    Kuang, Weipeng
    Kuo, Sally
    Kuperman, Samuel
    Liu, Yunlong
    McCutcheon, Vivia
    Pang, Zhiping
    Plawecki, Martin H.
    Schuckit, Marc
    Tischfield, Jay
    Wetherill, Leah
    Zang, Yong
    Edenberg, Howard J.
    Porjesz, Bernice
    Agrawal, Arpana
    Foroud, Tatiana
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 (03): : 374 - 383
  • [3] Polygenic risk scores for smoking: predictors for alcohol and cannabis use?
    Vink, Jacqueline M.
    Hottenga, Jouke Jan
    de Geus, Eco J. C.
    Willemsen, Gonneke
    Neale, Michael C.
    Furberg, Helena
    Boomsma, Dorret I.
    ADDICTION, 2014, 109 (07) : 1141 - 1151
  • [4] Effect of DNA methylation and AUDIT-C polygenic scores on alcohol use disorder comorbidity in psychoses: No evidence of epigenetic basis of polygenic risk
    Al-Chalabi, Nzaar
    Nader, George
    Fischer, Corinne
    Graff, Ariel
    Gerretsen, Philip
    De Luca, Vincenzo
    SCHIZOPHRENIA RESEARCH, 2024, 271 : 138 - 141
  • [5] Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders
    Calafato, Maria Stella
    Thygesen, Johan H.
    Ranlund, Siri
    Zartaloudi, Eirini
    Cahn, Wiepke
    Crespo-Facorro, Benedicto
    Diez-Revuelta, Alvaro
    Di Forti, Marta
    Hall, Mei-Hua
    Iyegbe, Conrad
    Jablensky, Assen
    Kahn, Rene
    Kalaydjieva, Luba
    Kravariti, Eugenia
    Lin, Kuang
    McDonald, Colm
    McIntosh, Andrew M.
    McQuillin, Andrew
    Picchioni, Marco
    Rujescu, Dan
    Shaikh, Madiha
    Toulopoulou, Timothea
    Van Os, Jim
    Vassos, Evangelos
    Walshe, Muriel
    Powell, John
    Lewis, Cathryn M.
    Murray, Robin M.
    Bramon, Elvira
    BRITISH JOURNAL OF PSYCHIATRY, 2018, 213 (03) : 535 - 541
  • [6] Polygenic risk prediction based on singular value decomposition with applications to alcohol use disorder
    Yang, James J.
    Luo, Xi
    Trucco, Elisa M.
    Buu, Anne
    BMC BIOINFORMATICS, 2022, 23 (01)
  • [7] The impact of the COVID-19 pandemic on alcohol use disorder symptoms: Testing interactions with polygenic risk
    Bountress, Kaitlin E.
    Bustamante, Daniel
    Ahangari, Mohammad
    Aliev, Fazil
    Aggen, Steven H.
    Lancaster, Eva
    Peterson, Roseann E.
    Vassileva, Jasmin
    Dick, Danielle M.
    Amstadter, Ananda B.
    JOURNAL OF AMERICAN COLLEGE HEALTH, 2025, 73 (04) : 1532 - 1537
  • [8] Investment in drinking identity is associated with alcohol consumption and risk of alcohol use disorder
    Hertel, Andrew W.
    Peterson, Kirsten P.
    Lindgren, Kristen P.
    ADDICTIVE BEHAVIORS, 2019, 89 : 256 - 262
  • [9] The use of polygenic risk scores to identify phenotypes associated with genetic risk of bipolar disorder and depression: A systematic review
    Mistry, Sumit
    Harrison, Judith R.
    Smith, Daniel J.
    Escott-Price, Valentina
    Zammit, Stanley
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 234 : 148 - 155
  • [10] Association of parental divorce, discord, and polygenic risk with children's alcohol initiation and lifetime risk for alcohol use disorder
    Kuo, Sally I-Chun
    Thomas, Nathaniel S.
    Aliev, Fazil
    Bucholz, Kathleen K.
    Dick, Danielle M.
    McCutcheon, Vivia V.
    Meyers, Jacquelyn L.
    Chan, Grace
    Kamarajan, Chella
    Kramer, John R.
    Hesselbrock, Victor
    Plawecki, Martin H.
    Porjesz, Bernice
    Tischfield, Jay
    Salvatore, Jessica E.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 (04): : 724 - 735